The University of Maryland Greenebaum Comprehensive Cancer Center received a $3 million award from the National Cancer Institute to expand next-generation cancer research training with a health equity focus. The funding is under the NCI’s Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program. For the biotech pipeline, K12-style awards can influence the talent supply that later drives translational oncology efforts, including clinical research capacity and career development in underrepresented communities. It also ties institutional training priorities to measurable workforce equity goals. The immediate impact will be recruitment and structured training for fellows under the program, with longer-term outcomes expected to show up in research productivity and the diversity of future clinical and translational leaders.